These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 8428477)
1. Physiologic response of stress and aminoglycoside clearance in critically ill patients. Tholl DA; Shikuma LR; Miller TQ; Woodward JM; Cerra FB; Zaske DE Crit Care Med; 1993 Feb; 21(2):248-51. PubMed ID: 8428477 [TBL] [Abstract][Full Text] [Related]
2. Relationship between hemodynamic and vital support measures and pharmacokinetic variability of amikacin in critically ill patients with sepsis. Lugo G; Castañeda-Hernández G Crit Care Med; 1997 May; 25(5):806-11. PubMed ID: 9187600 [TBL] [Abstract][Full Text] [Related]
3. Factors affecting gentamicin pharmacokinetics in septic patients. Tang GJ; Tang JJ; Lin BS; Kong CW; Lee TY Acta Anaesthesiol Scand; 1999 Aug; 43(7):726-30. PubMed ID: 10456812 [TBL] [Abstract][Full Text] [Related]
4. Serum aminoglycoside clearance is predicted as poorly by renal aminoglycoside clearance as by creatinine clearance in critically ill patients. Hickling KG; Begg EJ; Perry RE; Atkinson HC; Sharman JR Crit Care Med; 1991 Aug; 19(8):1041-7. PubMed ID: 1860329 [TBL] [Abstract][Full Text] [Related]
5. Prediction of glomerular filtration rate using aminoglycoside clearance in critically ill medical patients. Zarowitz BJ; Robert S; Peterson EL Ann Pharmacother; 1992 Oct; 26(10):1205-10. PubMed ID: 1421639 [TBL] [Abstract][Full Text] [Related]
6. Influence of sepsis on higher daily dose of amikacin pharmacokinetics in critically ill patients. Mahmoudi L; Mohammadpour AH; Ahmadi A; Niknam R; Mojtahedzadeh M Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):285-91. PubMed ID: 23426530 [TBL] [Abstract][Full Text] [Related]
7. Expanded gentamicin volume of distribution in critically ill adult patients receiving total parenteral nutrition. Ronchera-Oms CL; Tormo C; Ordovás JP; Abad J; Jiménez NV J Clin Pharm Ther; 1995 Oct; 20(5):253-8. PubMed ID: 8576291 [TBL] [Abstract][Full Text] [Related]
8. Aminoglycoside levels in critically ill surgical patients: the implications of physiologic criteria of sepsis. Cornwell EE; Belzberg H; Berne TV; Kern JW; Henriques G; Asensio JA; Demetriades D South Med J; 1997 Jan; 90(1):33-6. PubMed ID: 9003820 [TBL] [Abstract][Full Text] [Related]
9. Augmented renal clearance of aminoglycosides using population-based pharmacokinetic modelling with Bayesian estimation in the paediatric ICU. Avedissian SN; Rhodes NJ; Kim Y; Bradley J; Valdez JL; Le J J Antimicrob Chemother; 2020 Jan; 75(1):162-169. PubMed ID: 31648297 [TBL] [Abstract][Full Text] [Related]
10. Experience with a once-daily dosing program of aminoglycosides in critically ill patients. Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533 [TBL] [Abstract][Full Text] [Related]
11. Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides. Matthews I; Kirkpatrick C; Holford N Br J Clin Pharmacol; 2004 Jul; 58(1):8-19. PubMed ID: 15206987 [TBL] [Abstract][Full Text] [Related]
12. Influence of multiple courses of therapy on aminoglycoside clearance in adult patients with cystic fibrosis. Alghanem S; Paterson I; Touw DJ; Thomson AH J Antimicrob Chemother; 2013 Jun; 68(6):1338-47. PubMed ID: 23435691 [TBL] [Abstract][Full Text] [Related]
13. Effects of treatment and the metabolic response to injury on drug clearance: a prospective study with piperacillin. Shikuma LR; Ackerman BH; Weaver RH; Solem LD; Strate RG; Cerra FB; Zaske DE Crit Care Med; 1990 Jan; 18(1):37-41. PubMed ID: 2293966 [TBL] [Abstract][Full Text] [Related]
14. Modified Augmented Renal Clearance score predicts rapid piperacillin and tazobactam clearance in critically ill surgery and trauma patients. Akers KS; Niece KL; Chung KK; Cannon JW; Cota JM; Murray CK J Trauma Acute Care Surg; 2014 Sep; 77(3 Suppl 2):S163-70. PubMed ID: 24770557 [TBL] [Abstract][Full Text] [Related]
15. Prospective audit of costs and outcome of aminoglycoside treatment and of therapy for gram-negative bacteraemia. Davey PG; Parker SE; Orange G; Malek M; Dodd T J Antimicrob Chemother; 1995 Sep; 36(3):561-75. PubMed ID: 8830023 [TBL] [Abstract][Full Text] [Related]
16. Augmented renal clearance in the ICU: results of a multicenter observational study of renal function in critically ill patients with normal plasma creatinine concentrations*. Udy AA; Baptista JP; Lim NL; Joynt GM; Jarrett P; Wockner L; Boots RJ; Lipman J Crit Care Med; 2014 Mar; 42(3):520-7. PubMed ID: 24201175 [TBL] [Abstract][Full Text] [Related]
17. Effect of pharmacokinetic sampling methods on aminoglycoside dosing in critically ill surgery patients. Mann HJ; Wittbrodt ET; Baghaie AA; Cerra FB Pharmacotherapy; 1998; 18(2):371-8. PubMed ID: 9545157 [TBL] [Abstract][Full Text] [Related]
18. Studies on drug monitoring in thrice and once daily treatment with aminoglycosides. Konrad F; Wagner R; Neumeister B; Rommel H; Georgieff M Intensive Care Med; 1993; 19(4):215-20. PubMed ID: 8366230 [TBL] [Abstract][Full Text] [Related]
19. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis. Hodiamont CJ; Juffermans NP; Bouman CS; de Jong MD; Mathôt RA; van Hest RM Int J Antimicrob Agents; 2017 Feb; 49(2):204-211. PubMed ID: 28038961 [TBL] [Abstract][Full Text] [Related]
20. Suboptimal aminoglycoside dosing in critically ill patients. Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]